Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical's GHG Emissions Data Preview
In 2023, Chugai Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Chugai Pharmaceutical has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Chugai Pharmaceutical's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Chugai Pharmaceutical amounted to 112,654 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Chugai Pharmaceutical increased by 4.01%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Chugai Pharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Chugai Pharmaceutical's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Chugai Pharmaceutical were 47,991 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Chugai Pharmaceutical reduced its Scope 1 emissions over time?
Since 2019, Chugai Pharmaceutical's Scope 1 emissions have remained relatively, stable, indicating that Chugai Pharmaceutical's emissions have plateaued with no significant change in its operational footprint.
Compared to the previous year (2022), Chugai Pharmaceutical's Scope 1 emissions decreased by 4.52%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Chugai Pharmaceutical's Scope 2 emissions?
In 2023, Chugai Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 3,458 tCOâ‚‚e using the market-based method, and 64,663 tCOâ‚‚e using the location-based method.
Has Chugai Pharmaceutical reduced its Scope 2 emissions over time?
Since 2019, Chugai Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have remained relatively stable, indicating that Chugai Pharmaceutical 's emissions have plateaued with no significant change in its energy consumption footprint.
Compared to the previous year (2022), Chugai Pharmaceutical's Scope 2 emissions (Location-Based) rose by 11.4% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Chugai Pharmaceutical use for Scope 2 reporting?
In 2023, Chugai Pharmaceutical reported its Scope 2 emissions using the market-based method and using the location-based method.
Chugai Pharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Chugai Pharmaceutical's Value Chain Emissions
In 2023, Chugai Pharmaceutical reported 1,136,969 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Chugai Pharmaceutical includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Chugai Pharmaceutical's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Chugai Pharmaceutical's Scope 3 emissions?
In 2023, Chugai Pharmaceutical reported total Scope 3 emissions of 1,136,969 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 99.98% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.02% came from downstream activities like product use, distribution, and end-of-life treatment.
Has Chugai Pharmaceutical reduced its Scope 3 emissions over time?
Since 2019, Chugai Pharmaceutical's Scope 3 emissions have increased by 17.73%, reflecting a rising long-term trend in Scope 3 emissions over time.
Compared to the previous year (2022), Chugai Pharmaceutical's Scope 3 emissions decreased by 49.5%, highlighting the company's efforts to lower indirect emissions from its value chain.
What categories of Scope 3 emissions does Chugai Pharmaceutical disclose?
In 2023, Chugai Pharmaceutical reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Chugai Pharmaceutical's Scope 3 emissions?
In 2023, the largest contributors to Chugai Pharmaceutical's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 990,121 tCOâ‚‚e (87.08%)
- Capital Goods (Cat. 2): 79,339 tCOâ‚‚e (6.98%)
- Downstream Transportation and Distribution (Cat. 9): 29,808 tCOâ‚‚e (2.62%)
Chugai Pharmaceutical's Scope 3 Emissions by Categories
Insights into Chugai Pharmaceutical's Total Carbon Footprint
In 2023, Chugai Pharmaceutical reported a total carbon footprint of 1,249,623 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 47.04% decrease compared to 2022, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Chugai Pharmaceutical's total carbon footprint was Scope 3 emissions, accounting for 90.98% of the company's total carbon footprint, followed by Scope 2 emissions at 5.17%.